Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M110Revenue (TTM) $M69.4Net Margin (%)-75.5Altman Z-Score-4.0
Enterprise Value $M127EPS (TTM) $-0.5Operating Margin %-29.5Piotroski F-Score4
P/E(ttm)--Beneish M-Score-2.6Pre-tax Margin (%)-75.5Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio4.6Cash flow > EarningsY
Price/Sales1.65-y EBITDA Growth Rate %-7.1Current Ratio4.8Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-18.8Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M104ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with VVUS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VVUSFirst Eagle Investment 2013-06-30 Sold Out -0.0073%$10.43 - $15.1
($12.94)
$ 1.06-92%Sold Out0
VVUSFirst Eagle Investment 2013-03-31 Buy 0.01%$10.2 - $14.87
($12.43)
$ 1.06-91%New holding200,000
VVUSGeorge Soros 2012-09-30 Sold Out -0.06%$17.81 - $29.93
($23.45)
$ 1.06-95%Sold Out0
VVUSGeorge Soros 2012-06-30 Reduce-0.09%$21.5 - $28.68
($24.02)
$ 1.06-96%Reduce -64.93%150,000
VVUSGeorge Soros 2012-03-31 Buy 0.14%$9.99 - $23.78
($14.83)
$ 1.06-93%New holding427,750
VVUSGeorge Soros 2011-03-31 Sold Out $6.06 - $11.2
($7.95)
$ 1.06-87%Sold Out0
VVUSGeorge Soros 2010-12-31 Buy $5.94 - $9.78
($7.38)
$ 1.06-86%New holding19,400
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VVUS is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


VVUS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Varghese Santosh TChief Medical Officer 2016-08-02Sell12,559$1.07-0.93view
Varghese Santosh TVP, Medical & Reg Affairs 2016-07-01Sell366$1.21-12.4view
Varghese Santosh TChief Medical Officer 2016-04-07Sell329$1.65-35.76view
NORTH TIDE CAPITAL, LLC10% Owner 2016-04-01Buy2,160$1.4-24.29view
NORTH TIDE CAPITAL, LLC10% Owner 2016-03-31Buy383,300$1.29-17.83view
NORTH TIDE CAPITAL, LLC10% Owner 2016-03-28Buy202,000$1.12-5.36view
NORTH TIDE CAPITAL, LLC10% Owner 2016-03-16Buy500,000$1.21-12.4view
Varghese Santosh TChief Medical Officer 2016-01-13Sell1,553$0.9511.58view
Varghese Santosh TVP, Medical & Reg Affairs 2015-07-01Sell7,899$2.32-54.31view
Slebir John LSVP, Business Development & GC 2015-07-01Sell9,215$2.32-54.31view

Press Releases about VVUS :

Quarterly/Annual Reports about VVUS:

News about VVUS:

Articles On GuruFocus.com
Biotech Momentum Indicators: Achaogen (AKAO), Novartis (NVS), VIVUS (VVUS) Apr 01 2015 
5-year lows: PICO Holdings Inc, Black Box Corp, Vivus, and Electro Rent Corp. Mar 29 2015 
A Look at Pharma Company Dermira's Performance Mar 27 2015 
5-year lows: Vivus, Synta Pharmaceuticals Inc, MVC Capital Inc, and Kemet Corp. Feb 08 2015 
Revisiting Arena, Orexigen, And VIVUS: Shareholders Can Recoup Their Losses By Invest In MannKind Aug 19 2014 
Weekly Three-Year Low Highlight: VVUS, RALY, WILN, COVS Mar 25 2014 
Billionaires Hold Four Stocks, 59% Off Sep 30 2013 
Unique Investor Kyle Bass Unloads Five May 29 2013 
Weekly Guru Bargains Highlights: FTE, VVUS, PAY, TIBX, VMW Feb 24 2013 
Weekly Guru Bargains Highlights: FTNT, VVUS, HAE, PC, TIBX Dec 09 2012 

More From Other Websites
ETF’s with exposure to VIVUS, Inc. : August 26, 2016 Aug 26 2016
ETF’s with exposure to VIVUS, Inc. : August 12, 2016 Aug 12 2016
VIVUS INC Financials Aug 12 2016
VIVUS, Inc. :VVUS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016 Aug 11 2016
VIVUS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Aug 09 2016
Edited Transcript of VVUS earnings conference call or presentation 4-Aug-16 8:30pm GMT Aug 07 2016
Vivus reports 2Q loss Aug 04 2016
Vivus reports 2Q loss Aug 04 2016
VIVUS Reports 2016 Second Quarter Financial Results Aug 04 2016
VIVUS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Aug 04 2016
VIVUS Reports 2016 Second Quarter Financial Results Aug 04 2016
VIVUS INC Files SEC form 10-Q, Quarterly Report Aug 04 2016
Q2 2016 VIVUS Inc Earnings Release - After Market Close Aug 04 2016
VIVUS Files Lawsuit Against Hetero for Infringement of Stendra Patents Jul 27 2016
VIVUS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 27 2016
VIVUS Files Lawsuit Against Hetero for Infringement of Stendra Patents Jul 27 2016
VIVUS Announces Date of 2016 Second Quarter Business Update and Financial Results Teleconference Jul 26 2016
VIVUS Announces Date of 2016 Second Quarter Business Update and Financial Results Teleconference Jul 26 2016
VIVUS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 22 2016
VIVUS Announces Favorable Markman Ruling in Qsymia(R) Patent Litigation Jul 21 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)